InTandem Capital Partners, LLC (“InTandem Capital”), a healthcare services focused private equity firm, has announced its affiliated fund, InTandem Capital Partners Fund II, LP, has completed a growth equity investment in San Diego Fertility Center (“SDFC”), a leading fertility provider in Southern California. Cascadia Capital served as the exclusive financial advisor to SDFC.
San Diego Fertility Center is a world-class reproductive center committed to advancing the science of reproduction with the sole purpose of delivering success with compassion and individualized care. The collective experience of the physicians and the entire team at SDFC has solidified its position as a leader in the field. Since 1989, San Diego Fertility Center has brought thousands of miracle babies into the world helping families from across the US and around the globe.
InTandem Capital (“InTandem”) is a private equity firm that invests in, and helps accelerate the growth of, small- to mid-sized companies in select health care and insurance services sectors. In its pursuit of developing a strategy to create a leading fertility organization, InTandem viewed SDFC and its talented team of physicians as an ideal platform on which to further this strategy.
“Our decision to select a private equity investor was not something we took lightly. We were looking for a partner who understands our vision and has extensive experience helping regional companies expand nationally,” said Chief Executive Officer, Lisa Van Dolah. “It was clear to us upon our initial meeting with InTandem Capital that they have a unique approach to working with portfolio companies.”
“I have gotten to know Lisa and the team of superior fertility specialists at SDFC quite well over the past few years, and I am very happy that they have partnered with the talented team at InTandem,” said Kevin Cable, Managing Director and Head of Cascadia’s Healthcare group. “SDFC’s mission is to deliver exceptional care to each of their patients with the vision of helping as many people as possible achieve their dream of parenthood. Having a strong partner like InTandem Capital, who is also committed to this mission, will further enhance their ability to deliver excellence and successful outcomes to their patients.”
“I want to thank the Cascadia team for the introduction to InTandem,” added Ms. Van Dolah. “They made a complicated process very easy, and I can’t imagine doing it without their guidance and support.”
The acquisition represents another successful transaction for Cascadia in the healthcare and digital health sector. Recent client transactions include the sale of Mimic Technologies, a Seattle-based developer of virtual simulation solutions for robotic surgery, to Surgical Science, and the acquisition of Sonic Boom Wellness, a provider of corporate wellness technology, to Premise Health.
For more information about this transaction please contact a member of the Cascadia Capital Healthcare team:
Senior Vice President